Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

• Aptevo Therapeutics Inc APVO.OQ reported a quarterly adjusted loss of $8.40​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1,235.80. The lone analyst forecast for the quarter was for a loss of $83.20 per share.

• Reported revenue was zero​; analysts expected zero.

• Aptevo Therapeutics Inc's reported EPS for the quarter was a loss of $8.40​.

• The company reported a quarterly loss of $6.2 million.

• Aptevo Therapeutics Inc shares had fallen by 25.9% this quarter and lost 97.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

This summary was machine generated from LSEG data August 11 at 06:17 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)